Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

FirstWord Pharma
firstwordpharma.com > story > 7984983

WCLC26: GSK's ris-rez cuts death risk 54% in China Phase III lung cancer trial

3+ hour, 46+ min ago   (16+ words) FirstWord Pharma...

firstwordpharma.com
firstwordpharma.com > story > 7983565

AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial

12+ hour, 56+ min ago   (12+ words) firstwordpharma.com...

firstwordpharma.com
firstwordpharma.com > story > 7969456

Spotlight On: What to watch at World Lung 2026

3+ day, 14+ hour ago   (10+ words) firstwordpharma.com...

FirstWord Pharma
firstwordpharma.com > story > 7967524

TwoStep's take on targeting solid tumours gains backing from Merck KGaA, Pfizer venture arms

4+ day, 2+ hour ago   (16+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7967761

Solstice raises $225M to advance next-gen CTLA-4 immunotherapy

4+ day, 1+ hour ago   (10+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7966709

Tyra remains upbeat after oral bladder cancer drug misses study expectations

4+ day, 6+ hour ago   (13+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7966036

Kura spins out Caspian to take menin inhibitor into diabetes

4+ day, 7+ hour ago   (12+ words) FirstWord Pharma...

FirstWord PHARMA
firstwordpharma.com > story > 7961829

Pharvaris' oral HAE hopeful significantly cuts attacks in pivotal study

5+ day, 41+ min ago   (12+ words) FirstWord PHARMA...

FirstWord PHARMA
firstwordpharma.com > story > 7961783

Amgen claims win for Imdelltra in maintenance lung cancer setting

5+ day, 55+ min ago   (12+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7960381

Next-gen CAR-T from BMS passes pivotal test in quadruple-class exposed myeloma

5+ day, 6+ hour ago   (13+ words) FirstWord Pharma...